MEDADENT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDADENT
Largest movements
- Receivables within one year +€106,301
up €106,301 (+11.6%), from €918,825 to €1.0m
- Cash -€27,075
down €27,075 (-40.4%), from €66,989 to €39,914
mainly Receivables within one year (-€106,301)
- Reserves +€77,840
up €77,840 (+8.1%), from €958,006 to €1.0m
of which Distributable reserves: +€77,840
- Gross operating margin -€39,352
down €39,352 (-38.4%), from €102,464 to €63,112
- Taxes -€12,119
down €12,119 (-27.3%), from €44,418 to €32,300
- Financial income -€1,582
down €1,582 (-3.0%), from €52,779 to €51,197
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €995,823 | €1,073,662 | +€77,840 | +7.8% |
| Fixed assets | 21/28 | €10,009 | €8,623 | -€1,386 | -13.9% |
| Tangible fixed assets | 22/27 | €7,509 | €6,123 | -€1,386 | -18.5% |
| Land and buildings | 22 | €7,509 | €6,123 | -€1,386 | -18.5% |
| Financial fixed assets | 28 | €2,500 | €2,500 | = | 0.0% |
| Current assets | 29/58 | €985,813 | €1,065,039 | +€79,226 | +8.0% |
| Amounts receivable within one year | 40/41 | €918,825 | €1,025,125 | +€106,301 | +11.6% |
| Other amounts receivable | 41 | €918,825 | €1,025,125 | +€106,301 | +11.6% |
| Cash at bank and in hand | 54/58 | €66,989 | €39,914 | -€27,075 | -40.4% |
| Total equity and liabilities | 10/49 | €995,823 | €1,073,662 | +€77,840 | +7.8% |
| Equity | 10/15 | €970,406 | €1,048,246 | +€77,840 | +8.0% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €958,006 | €1,035,846 | +€77,840 | +8.1% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Tax-exempt reserves | 132 | €451 | €451 | = | 0.0% |
| Distributable reserves | 133 | €955,695 | €1,033,535 | +€77,840 | +8.1% |
| Amounts payable | 17/49 | €25,417 | €25,417 | = | 0.0% |
| Amounts payable within one year | 42/48 | €25,417 | €25,417 | = | 0.0% |
| Financial debts | 43 | €25,417 | €25,417 | = | 0.0% |
| Credit institutions | 430/8 | €25,417 | €25,417 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,386 | €1,386 | = | 0.0% |
| Other operating charges | 640/8 | €348 | €743 | +€394 | +113% |
| Gross operating margin | 9900 | €102,464 | €63,112 | -€39,352 | -38.4% |
| Operating profit (loss) | 9901 | €100,729 | €60,983 | -€39,746 | -39.5% |
| Financial income | 75/76B | €52,779 | €51,197 | -€1,582 | -3.0% |
| Recurring financial income | 75 | €52,779 | €51,197 | -€1,582 | -3.0% |
| Financial charges | 65/66B | €2,284 | €2,041 | -€243 | -10.6% |
| Recurring financial charges | 65 | €2,284 | €2,041 | -€243 | -10.6% |
| Profit (loss) for the period before taxes | 9903 | €151,224 | €110,139 | -€41,085 | -27.2% |
| Income taxes | 67/77 | €44,418 | €32,300 | -€12,119 | -27.3% |
| Profit (loss) for the period | 9904 | €106,806 | €77,840 | -€28,966 | -27.1% |
| Profit (loss) for the period to be appropriated | 9905 | €106,806 | €77,840 | -€28,966 | -27.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.